This meeting was the first in the President’s Cancer Panel’s (PCP, the Panel) 2010-2011 series, The Future of Cancer Research: Accelerating Scientific Innovation. During this meeting, the Panel heard expert testimony and moderated discussions regarding scientific progress made over the past four decades and opportunities to enhance the National Cancer Program (NCP) in coming years. The agenda for the meeting was organized into two discussion panels.
President’s Cancer Panel
LaSalle D. Leffall, Jr., M.D., F.A.C.S., Chair
Margaret Kripke, Ph.D.
National Cancer Institute (NCI), National Institutes of Health (NIH )
Abby Sandler, Ph.D., Executive Secretary, PCP
John Auerbach, M.B.A., President-Elect, Association of State and Territorial Health Officials
Edward J. Benz, Jr., M.D., President, Dana-Farber Cancer Institute
Otis W. Brawley, M.D., Chief Medical Officer, American Cancer Society
Bruce Chabner, M.D., Co-Chair, The National Cancer Advisory Board’s Ad hoc Working Group to Create a Strategic Scientific Vision for the National Cancer Program and Review of the National Cancer Institute
Gwen Darien, Chair, Director’s Consumer Liaison Group, National Cancer Institute
James Doroshow, M.D., Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute Judy E. Garber, M.D., M.P.H., President-Elect, American Association for Cancer Research
Peter Grevatt, Ph.D., Director, Office of Children's Health Protection and Environmental Education, Environmental Protection Agency
William Hait, M.D., Ph.D., Senior Vice President and Worldwide Head, Ortho Biotech Oncology Research & Development, a Unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Brandon Hayes-Lattin, M.D., Senior Medical Advisor, Lance Armstrong Foundation
Michael Kelley, M.D., F.A.C.P., National Program Director for Oncology, Veterans Health Administration, Department of Veterans Affairs
Sharyl Nass, Ph.D., Director, National Cancer Policy Forum, Institute of Medicine
Richard Pazdur, M.D., F.A.C.P., Director, Office of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration
Kyu Rhee, M.D., M.P.P., F.A.A.P., F.A.C.P., Chief Public Health Officer, Health Resources and Services Administration
Lisa Richardson, M.D., M.P.H., Associate Director for Science, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention
George W. Sledge, Jr., M.D., President, American Society of Clinical Oncology
Barry Straube, M.D., Chief Medical Officer, Centers for Medicare and Medicaid Services